Back

Antiplatelet drugs: clinically relevant details on the pharmacology of P2Y12 inhibitors

26 August 2023 (11:40 - 11:55)
Organised by: Logo
Congress Presentation Part of: Pharma Made Easy Pharmacology and Pharmacotherapy ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Professor Steffen Massberg

Ludwig Maximilians University, Munich (Germany)

5 More presentations in this session

Presentation thumbnail
Lipid lowering agents: how to make optimal use of the full spectrum
Professor F. Mach (Geneva, CH)
Slides
Presentation thumbnail
Lipid lowering agents: how to make optimal use of the full spectrum - discussion
Presentation thumbnail
GLP-1 agonists: how do they work?
Professor U. Laufs (Leipzig, DE)
Slides
Presentation thumbnail
GLP-1 agonists: how do they work? - discussion
Presentation thumbnail
Antiplatelet drugs: clinically relevant details on the pharmacology of P2Y12 inhibitors - discussion

Access the full session

Session thumbnail
Pharma Made Easy

The Event

Event poster

ESC Congress 2023

26 August 2023 11:40 CET
You may be interested in
thumbnail
Congress Presentation
Selatogrel, a novel P2Y12 inhibitor for emergency use, achieves rapid, consistent and sustained platelet inhibition following single-dose subcutaneous administration in stable CAD patients
1 September 2019
thumbnail
Webinar
Aspirin treatment for mitigating thrombotic risk across the cardiovascular risk continuum
6 July 2023
thumbnail
Congress Presentation
Efficacy and safety of potent p2y12 inhibitors versus clopidogrel in complex percutaneous coronary intervention: a systematic review and meta-analysis
1 September 2025
thumbnail
Congress Presentation
Antiplatelet therapy prescription patterns for acute coronary syndrome: a decade analysed
28 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources